{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:41:37Z","timestamp":1771461697619,"version":"3.50.1"},"reference-count":26,"publisher":"S. Karger AG","issue":"2","license":[{"start":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T00:00:00Z","timestamp":1274400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T00:00:00Z","timestamp":1274400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nephron Clin Pract"],"abstract":"<jats:p>&lt;i&gt;Background\/Objectives:&lt;\/i&gt; Microalbuminuria (MA) detects subjects at risk for cardiovascular disease (CVD) and chronic kidney disease (CKD) among diabetics, hypertensives and the general population. There is still a paucity of data on prevalence and risk factors for MA in the UK. We examined in a cross-sectional study, the prevalence and risk factors for MA in the general population of Sheffield, UK. &lt;i&gt;Methods:&lt;\/i&gt; The study was conducted among participants of the Kidney Evaluation and Awareness Program in Sheffield (KEAPS), a population-based screening program for MA. The screening tools included a questionnaire collating information on demographics, lifestyle, medical and family history of diabetes mellitus, hypertension and CKD. MA measurements were obtained by immunonephelometry, and MA thresholds were defined using the albumin-creatinine ratio. &lt;i&gt;Results:&lt;\/i&gt; The prevalence of MA was 7.1% in a random sample of a Sheffield-based population screened only once. The prevalence was 6.2% in the non-diabetic and non-hypertensive subjects. The prevalence of MA was only 1.3% in the subjects without any known risk factor, such as old age, diabetes, hypertension, obesity or CVD. The prevalence of MA could be overestimated as it was based on a single albumin-creatinine ratio testing. The independent predictor variables associated with the presence of MA in a mutually adjusted logistic regression model were: age (OR = 1.012, 95% CI: 1.00\u20131.02), diabetes (OR = 3.25, 95% CI: 1.30\u20138.13), obesity (OR = 4.09, 95% CI: 1.71\u20139.80) and family history of hypertension (OR = 1.87, 95% CI: 1.00\u20133.47). &lt;i&gt;Conclusions:&lt;\/i&gt; The main determinants of MA were increased age, diabetes, obesity and family history of hypertension. On the population level, obesity as a risk factor for MA is less well documented; in this study obesity had greater odds for MA than diabetes and hypertension.<\/jats:p>","DOI":"10.1159\/000314658","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T07:19:37Z","timestamp":1274426377000},"page":"c95-c103","source":"Crossref","is-referenced-by-count":11,"title":["The Kidney Evaluation and Awareness Program in Sheffield (KEAPS): A Community-Based Screening for Microalbuminuria in a British Population"],"prefix":"10.1159","volume":"116","author":[{"given":"Aminu K.","family":"Bello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Wight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meguid","family":"El Nahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2010,5,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1523-1755.2004.09205.x"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1524-6175.2001.00442.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1523-1755.2004.09201.x"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053%2Fajkd.2002.31388"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046%2Fj.1365-2796.2001.00833.x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097%2F01.ASN.0000070152.11927.4A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016%2F0021-9150%2892%2990201-Q"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136%2Fbmj.306.6872.240"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093%2Fije%2Fdyh008"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038%2Fsj.ki.5002343"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053%2Fajkd.2003.50007"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016%2FS0272-6386%2803%2900742-X"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097%2F01.hjr.0000133070.75016.1d"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1523-1755.2005.09408.x"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001%2Farchinte.158.17.1933"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053%2Fj.ajkd.2005.06.007"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001%2Fjama.291.7.844"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097%2F01.hjh.0000226206.03560.ac"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093%2Fndt%2Fgfm091"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161%2F01.CIR.0000158434.69180.2D"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.jacc.2004.07.027"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053%2Fj.ajkd.2006.02.179"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046%2Fj.1369-6513.2001.00150.x"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136%2Fjech.54.2.143"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038%2Fsj.ijo.0801375"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.jclinepi.2004.04.005"}],"container-title":["Nephron Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/314658","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/314658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T19:22:44Z","timestamp":1745436164000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000314658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,21]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000314658","archive":["Portico"],"relation":{},"ISSN":["1660-2110"],"issn-type":[{"value":"1660-2110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,21]]}}}